Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity
- PMID: 8411338
- PMCID: PMC238071
- DOI: 10.1128/JVI.67.11.6365-6378.1993
Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity
Abstract
Multiple RNA splicing sites exist within human immunodeficiency virus type 1 (HIV-1) genomic RNA, and these sites enable the synthesis of many mRNAs for each of several viral proteins. We evaluated the biological significance of the alternatively spliced mRNA species during productive HIV-1 infections of peripheral blood lymphocytes and human T-cell lines to determine the potential role of alternative RNA splicing in the regulation of HIV-1 replication and infection. First, we used a semiquantitative polymerase chain reaction of cDNAs that were radiolabeled for gel analysis to determine the relative abundance of the diverse array of alternatively spliced HIV-1 mRNAs. The predominant rev, tat, vpr, and env RNAs contained a minimum of noncoding sequence, but the predominant nef mRNAs were incompletely spliced and invariably included noncoding exons. Second, the effect of altered RNA processing was measured following mutagenesis of the major 5' splice donor and several cryptic, constitutive, and competing 3' splice acceptor motifs of HIV-1NL4-3. Mutations that ablated constitutive splice sites led to the activation of new cryptic sites; some of these preserved biological function. Mutations that ablated competing splice acceptor sites caused marked alterations in the pool of virus-derived mRNAs and, in some instances, in virus infectivity and/or the profile of virus proteins. The redundant RNA splicing signals in the HIV-1 genome and alternatively spliced mRNAs provides a mechanism for regulating the relative proportions of HIV-1 proteins and, in some cases, viral infectivity.
Similar articles
-
Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages.J Virol. 1990 Jul;64(7):3391-8. doi: 10.1128/JVI.64.7.3391-3398.1990. J Virol. 1990. PMID: 2191150 Free PMC article.
-
Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel tat-env fusion protein.Virology. 1991 Nov;185(1):258-70. doi: 10.1016/0042-6822(91)90773-5. Virology. 1991. PMID: 1926777
-
Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs.J Biol Chem. 1998 Dec 18;273(51):34551-7. doi: 10.1074/jbc.273.51.34551. J Biol Chem. 1998. PMID: 9852125
-
Chapter 1. Regulation of HIV-1 alternative RNA splicing and its role in virus replication.Adv Virus Res. 2009;74:1-40. doi: 10.1016/S0065-3527(09)74001-1. Adv Virus Res. 2009. PMID: 19698894 Review.
-
HIV-1: To Splice or Not to Splice, That Is the Question.Viruses. 2021 Jan 26;13(2):181. doi: 10.3390/v13020181. Viruses. 2021. PMID: 33530363 Free PMC article. Review.
Cited by
-
The Life-Cycle of the HIV-1 Gag-RNA Complex.Viruses. 2016 Sep 10;8(9):248. doi: 10.3390/v8090248. Viruses. 2016. PMID: 27626439 Free PMC article. Review.
-
RNA interference approaches for treatment of HIV-1 infection.Genome Med. 2015 May 28;7(1):50. doi: 10.1186/s13073-015-0174-y. eCollection 2015. Genome Med. 2015. PMID: 26019725 Free PMC article.
-
Co-expression of HIV-1 virus-like particles and granulocyte-macrophage colony stimulating factor by GEO-D03 DNA vaccine.Hum Vaccin Immunother. 2012 Nov 1;8(11):1654-8. doi: 10.4161/hv.21978. Epub 2012 Oct 30. Hum Vaccin Immunother. 2012. PMID: 23111169 Free PMC article. Review.
-
The multifaceted nature of HIV latency.J Clin Invest. 2020 Jul 1;130(7):3381-3390. doi: 10.1172/JCI136227. J Clin Invest. 2020. PMID: 32609095 Free PMC article. Review.
-
A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication.Retrovirology. 2006 Feb 3;3:10. doi: 10.1186/1742-4690-3-10. Retrovirology. 2006. PMID: 16457729 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources